Abstract:Feline calicivirus (FCV) is one of the most important pathogens causing upper respiratory tract diseases in cats, posing a serious health threat to these animals. At present, FCV is mainly prevented through vaccination, but the protective efficacy of vaccines in China is limited. In this study, based on the differences in capsid proteins of isolates from different regions in China, as reported in our previous studies, seven representative FCV epidemic strains were selected and tested for their viral titers, virulence, immunogenicity, and extensive cross-protection. Subsequently, vaccine strains were selected to prepare inactivated vaccines. The whole-genome sequencing and analysis results showed that these seven representative FCV strains and 144 reference strains fell into five groups (A, B, C, D, and E). The strains isolated in China mainly fall into groups C and D, exhibiting regional characteristics. These Chinese isolates had a distant evolutionary relationship and low homology with the current FCV-255 vaccine strain. The screened FCV-HB7 and FCV-HB10 strains displayed desirable in vitro culture characteristics, with the highest virus proliferation titers (109.5 TCID50/mL) at 36 h post inoculation at a dose of 0.01 MOI. All five cats infected intranasally with FCV-HB7 or FCV-HB10 strains showed obvious clinical symptoms of FCV. The symptoms of cats infected with the FCV-HB7 strain were more severe than those infected with the FCV-HB10 strain. Both the single-strain inactivated immunization and combined bivalent inactivated vaccine immunization of FCV-HB7 and FCV-HB10 induced high neutralizing antibody titers in five cats immunized. Moreover, bivalent inactivated vaccine immunization protected cats from FCV-HB7 and FCV-HB10 strains. The cross-neutralizing antibody titer against seven representative FCV epidemic strains achieved by combined bivalent inactivated vaccine immunization was higher than that achieved by single-strain immunization, which was much higher than that achieved by commercial vaccine FCV-255 strain immunization. The above results suggest that the FCV-HB7 and FCV-HB10 strains screened in this study have great potential to become vaccine strains with broad-spectrum protective efficacy. However, their immune protective efficacy needs to be further verified by multiple methods before clinical application.

Assessing Immune Evasion Potential and Vaccine Suitability of a Feline Panleukopenia Virus Strain

Biological Characteristics of Feline Calicivirus Epidemic Strains in China and Screening of Broad-Spectrum Protective Vaccine Strains

Immunogenicity of a new inactivated vaccine against feline panleukopenia virus, calicivirus, and herpesvirus-1 for cats

Screening and Immune Efficacy Evaluation of Antigens with Protection Against Feline Calicivirus

Isolation of a Feline-Derived Feline Panleukopenia Virus with an A300P Substitution in the VP2 Protein and Confirmation of Its Pathogenicity in Dogs

Development of a recombinant Lactobacillus plantarum oral vaccine expressing VP2 protein for preventing feline panleukopenia virus

Assessment of the Protective Efficacy of a Feline Calicivirus Inactivated Vaccine Using in Vivo FCV CH-JL2 Infection

Complete protection of cats against feline panleukopenia virus challenge by a recombinant canine adenovirus type 2 expressing VP2 from FPV

Classification of genotypes based on the VP1 gene of feline calicivirus and study of cross-protection between different genotypes

Genetic analysis of CPV vaccine strain NL-35-D and evaluation of induced neutralizing antibody against virulent wild-type CPV and FPV Shanghai isolates

Epidemiological Investigation of Feline Upper Respiratory Tract Infection Encourages a Geographically Specific FCV Vaccine

Identification and Genome Characterization of Novel Feline Parvovirus Strains Isolated in Shanghai, China

Molecular Characterization of Feline Parvovirus from Domestic Cats in Henan Province, China from 2020 to 2022

Investigation on Feline Panleukopenia Cases in Pet Cats of Xi'an City from 2013 to 2015

Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus

Development of a reverse genetics system for a feline panleukopenia virus

Molecular Characterization and Cross-Reactivity of Feline Calicivirus Circulating in Southwestern China

A Potential Dual Protection Vaccine: Recombinant Feline Herpesvirus-1 Expressing Feline Parvovirus VP2 Antigen

Prevalence and Molecular Characterization of Parvovirus in Domestic Kittens from Northeast China During 2016-2017

Epidemiological Survey of Feline Viral Infectious Diseases in China from 2018 to 2020

China-origin G1 Group Isolate FPV072 Exhibits Higher Infectivity and Pathogenicity Than G2 Group Isolate FPV027